TL;DR
- Idea: Decentralized science (DeSci) platform enabling AI-driven research networks for biotech funding and tokenized launches.
- Catalyst: Recent AI-native V2 launch, multichain expansion to Solana & Base, trending search momentum and institutional backing.
- Risks: Regulatory uncertainty in tokenized biotech funding; adoption risk of DeSci paradigm; limited team transparency; competitive landscape.
- Score: 7.00/ 10
Coin
- Name/ Ticker: Bio Protocol (BIO)
- Segment: DeSci
- Status: active
- Price: $0.057830
Key Metrics
- Market Cap: $122 964 488
- FDV: $190 320 079
- Circulating Supply: 2 430 694 769
- Total Supply: 3 320 000 000
Sources
Technology
- USP: AI-native decentralized science platform for funding and automating biotech research pipelines.
- Core Technology: Agentic AI frameworks (BioAgents) orchestrating scientific tasks; permissionless onchain fundraising via BioDAOs; tokenized IP models.
Roadmap
- 2025-01-01: Multichain expansion to Solana and Base
- 2025-01-03: Token Generation Event on Ethereum mainnet
- 2025-09-17: Launch of Bio Protocol V2 with onchain fundraising and AI-driven frameworks
Team & Investors
Team
- Founder & CEO — Vincent Weisser:
- Co-Founder — Paul Kohlhaas:
- CTO — Ryan Noble:
Investors
- Maelstrom Fund — Seed • 2025-09-17 • $6.90M
- Binance Labs — Strategic • 2024-11-01
- Enterprise — Enterprise • 2024-08-19
- Miscellaneous — Miscellaneous • 2024-08-19
- Binance Launchpool — Launchpool • 2025-01-03
Total funding: $6.90M
Tokenomics
- Utility: Governance, staking (veBIO), launchpad participation, onchain fundraising and fee accrual.
Pros & Cons
Strengths
- Innovative AI-driven decentralized science framework
- Growing multichain presence (Ethereum, Solana, Base)
- Low market cap enables high growth potential
- Strong trending momentum on CoinGecko
- Institutional backing by Maelstrom Fund
Weaknesses
- Regulatory uncertainties around tokenized biotech funding
- Early adoption risk of DeSci model
- Relatively small community and onchain TVL
- Limited public team disclosure
- Competition from emerging DeSci protocols
Market Signals (7d)
- CEX volume trend: up
- Active addresses trend: up
Price Scenarios (target: 2026-11-03)
- Bear: $0.028000 — Assumes 50% decline from current price
- Base: $0.063600 — Assumes 10% appreciation from current price
- Bull: $0.115700 — Assumes 100% appreciation from current price
How to Buy & Store
CEX
- OKX
- Gate
- Coinbase Exchange
- Binance
- Upbit
- KuCoin
DEX
- Uniswap
- PancakeSwap
- SushiSwap
- 1inch
- Balancer
Storage
- MetaMask
- Trust Wallet
- Ledger
- Trezor
- Coinbase Wallet
Verdict
Bio Protocol combines novel AI-native DeSci infrastructure with robust tokenomics and multichain expansion, presenting strong growth catalysts despite regulatory and adoption risks.
Official Links
Source: Coin Research (internal)
Comments (0)